Neck dissection in the combined‐modality therapy of patients with locoregionally advanced head and neck cancer

Abstract

ND improves neck control and is required for patients with clinically residual disease or N3 neck cancer but has no significant impact on the outcome of patients with N2 stage disease who are rendered clinically disease-free with intensive concurrent chemoradiotherapy.